We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+9.18%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.2B
AUM Growth
-$255M
Cap. Flow
-$342M
Cap. Flow %
-28.37%
Top 10 Hldgs %
51.29%
Holding
4,943
New
709
Increased
1,153
Reduced
1,646
Closed
1,310

Sector Composition

Rank Sector Weight
1 Technology 2.73%
2 Financials 2.53%
3 Healthcare 2.3%
4 Consumer Discretionary 2.11%
5 Industrials 1.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EGOV
1501
DELISTED
NIC Inc
EGOV
$39K ﹤0.01%
+1,727
New +$37.8K
CVIA
1502
DELISTED
Covia Holdings Corporation Common Stock
CVIA
$39K ﹤0.01%
18,884
+9,340
+98% +$15.1K
ARCO icon
1503
Arcos Dorados Holdings
ARCO
$1.74B
$38K ﹤0.01%
+4,874
New +$35.2K
BBIO icon
1504
BridgeBio Pharma
BBIO
$16.5B
$38K ﹤0.01%
1,097
+634
+137% +$17.6K
CLF icon
1505
Cleveland-Cliffs
CLF
$6.99B
$38K ﹤0.01%
4,556
-292
-6% -$2.24K
EFR
1506
Eaton Vance Senior Floating-Rate Fund
EFR
$317M
$38K ﹤0.01%
+2,834
New +$37K
EFT
1507
Eaton Vance Floating-Rate Income Trust
EFT
$288M
$38K ﹤0.01%
+2,795
New +$37.3K
EXAS
1508
DELISTED
Exact Sciences
EXAS
$38K ﹤0.01%
410
-1,279
-76% -$112K
FLEX icon
1509
Flex
FLEX
$44.8B
$38K ﹤0.01%
3,974
-1,362
-26% -$11.7K
IVOG icon
1510
Vanguard S&P Mid-Cap 400 Growth ETF
IVOG
$1.7B
$38K ﹤0.01%
516
-3,008
-85% -$214K
NI icon
1511
NiSource
NI
$20.4B
$38K ﹤0.01%
1,354
-13,773
-91% -$378K
SSL icon
1512
Sasol
SSL
$7.1B
$38K ﹤0.01%
1,767
+422
+31% +$8.07K
VHI icon
1513
Valhi
VHI
$450M
$38K ﹤0.01%
1,676
+1,502
+863% +$34.5K
SPPI
1514
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$38K ﹤0.01%
10,346
+7,401
+251% +$59.8K
ARNA
1515
DELISTED
Arena Pharmaceuticals Inc
ARNA
$38K ﹤0.01%
846
+845
+84,500% +$39.9K
MIK
1516
DELISTED
Michaels Stores, Inc
MIK
$38K ﹤0.01%
4,750
+3,251
+217% +$27.3K
SDRL
1517
DELISTED
Seadrill Limited Common Stock
SDRL
$38K ﹤0.01%
14,805
+14,138
+2,120% +$23.4K
BYD icon
1518
Boyd Gaming
BYD
$6.06B
$37K ﹤0.01%
1,230
-2,630
-68% -$74K
CHRW icon
1519
C.H. Robinson
CHRW
$17.5B
$37K ﹤0.01%
474
-3,311
-87% -$264K
CRNC icon
1520
Cerence
CRNC
$413M
$37K ﹤0.01%
+1,646
New +$27K
GLMD icon
1521
Galmed Pharmaceuticals
GLMD
$4.97M
$37K ﹤0.01%
+35
New +$30.1K
IHG icon
1522
InterContinental Hotels
IHG
$23.2B
$37K ﹤0.01%
539
+92
+21% +$5.73K
INCY icon
1523
Incyte
INCY
$24.4B
$37K ﹤0.01%
417
-2,595
-86% -$222K
NNN icon
1524
NNN REIT
NNN
$8.99B
$37K ﹤0.01%
682
-660
-49% -$36.7K
RCL icon
1525
Royal Caribbean
RCL
$85.6B
$37K ﹤0.01%
273
-5,130
-95% -$598K

Similar funds

Tower Research Capital (TRC)'s Q4 2019 Portfolio in Review

As of Q4 2019, Tower Research Capital (TRC) held 4,943 positions worth $1.2B, down 17% from $1.46B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Tower Research Capital (TRC) withdrew a net $342M in Q4 2019, closing 1,310 positions and reducing 1,646 holdings. Its most notable exit was Wells Fargo, an estimated $7.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 9.1% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core S&P 500 ETF worth $24.4M.

  • Tower Research Capital (TRC)'s largest Q4 2019 buy was iShares Core S&P 500 ETF: 75,634 shares worth $24.4M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $168M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2019 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $52.3M.
  • Tower Research Capital (TRC) fully exited Wells Fargo in Q4 2019, selling an estimated $7.5M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 51% of its $1.2B portfolio in Q4 2019.
  • Tower Research Capital (TRC) opened 709 new positions and closed 1,310 in Q4 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 17% quarter-over-quarter to $1.2B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2019, filed 7 Feb 2020.